Skip to main content
DRIO logo

DRIO · DarioHealth Corp.

Track DRIO — free
$6.93 +0.35 (+5.32%) At close · Sep 11
Market Cap
$67.91M
Shares
9.80M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$6.93 Open$6.70 Day$6.67–7.07 52W close$5.99–17.35 Avg vol 30d29K Short int75K · 0.8% float · 2.9d Short vol69% Last earningsMar 31, 2026 DataAug 2025–Sep 2026 Filing10-Q · Aug 11

Raw chart and full-history price indicators begin at the captured split on Aug 28, 2025; bars on opposite sides are not compared.

Up next

filed Aug 11, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$21.00M
Trailing 12 months
Net income (TTM)
−$35.67M
Trailing 12 months
Revenue growth YoY
-3.6%
Year over year
Operating margin
-151.6%
Trailing 12 months
P / E (TTM)
1.2
Trailing earnings · reciprocal yield 83.8%
FCF yield
-37.5%
TTM · current market cap
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Dividend yield
Trailing 12 months
Shares change YoY
+276.5%
Year over year · more shares
Price change (1Y)
-2.3%
Trailing year
Short interest
0.8%
Latest settlement · 2.9 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bullish Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 15.8 · calm Equity put/call 0.60
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −22%
below
Price vs 50-day avg −4%
below
RSI (14) 47
neutral
MACD trend Negative
52-week position 8%
near low
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Very Weak
1-month return −5%
trailing
6-month return −13%
trailing
YTD return −39%
this year
Relative strength −31%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $7 › 200d $9 — 200d above 50d
Institutional flow Flat
0% holders QoQ · +2 funds added
Insider flow Accumulating
Net +$100.0K over 90 days · 0% sells
Short interest Falling
0.77% of float · ▼ -9.4% MoM · 2.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
21 holders — mid 3-yr range
Squeeze score 47
elevated · 0–100
Fundamentals
Fair
Revenue growth +43%
Y/Y
Gross margin 171%
contracting
EPS growth −18%
Y/Y
Free cash flow $-26.1M
Quant / Vol
risk profile
Very High
Volatility 99%
annualized · 1-yr
Max drawdown −65%
past year
ATR 8.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Dec 31, 2025
Non-GAAP operating loss reduction · 2026 Non-GAAP 30%
Prior guidance period ended · from the Earnings Call filed Dec 31, 2021
Gross margins · full year 2022 50% – 60%
Gross margins · 2022 50% – 60%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−22% Bearish
Price vs 50-day avg
−4% Neutral
RSI (14)
47 Neutral
MACD trend
Negative Bearish
52-week position
8% Bearish
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $7 › 200d $9 — 200d above 50d
Institutional flow Flat
0% holders QoQ · +2 funds added
Insider flow Accumulating
Net +$100.0K over 90 days · 0% sells
Short interest Falling
0.77% of float · ▼ -9.4% MoM · 2.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
21 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $6 Now $7 · 8% Range high $17
vs 200-day avg -22% vs 50-day avg -4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Health Information Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
DRIO
DarioHealth Corp.
this stock
$67.91M -39.1% +43.0% 0.8%
VEEV
Veeva Systems Inc
$42.48B +17.5% +28.1% 43.0 3.0%
PMDIY
Pro Medicus Ltd./ADR
$12.54B -27.7% 0.0%
BTSG
BrightSpring Health Services, Inc.
$11.62B +56.8% +28.2% 35.6 5.1%
TEM
Tempus AI, Inc.
$10.65B -0.1% +83.4% 16.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
21
% held
8.7%
Net QoQ
+14.1K sh
Top holder
Nantahala Capital Managem…
Held Float
View
Held by Funds
Fund positions
12
View
Short & Settlement
Short Interest Falling
Shares short
75.1K
Days to cover
2.9d
Change
-7.8K sh
View
Short Volume
Short vol %
69%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
48.2K
Value
$380.8K
As of
Jul 23, 2026
View
Off-Exchange
Off-exchange %
61.0%
Week of
Aug 3, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$100.0K
Buyers / Sellers
1 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$7.4M
Net income (FY)
$-41.7M
EPS diluted
$10.12
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 4, 2026
This year
11
View
Exempt Offerings
Offering
$17.5M
Filed
Oct 7, 2025
View
Earnings & Events
Earnings Calls
Last call
Mar 31, 2026
View

Performance

Raw-price comparisons begin at the captured split on Aug 28, 2025; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
DRIO -0.7% -5.5% -13.3% -6.0% -39.1%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY +0.4% -3.7% -31.1% -5.6% -51.2%
Key facts CIK 1533998 CUSIP 23725P308 13F (30d) 15 filings 15 filers Visit website Investor relations